Target intelligence / Profile preview

Inositol phosphorylceramide synthase catalytic subunit AUR1 (AUR1)

Target
AUR1
Molecular classification
Enzyme
01

Overview

The Inositol phosphorylceramide synthase catalytic subunit AUR1 (AUR1) is an enzyme in the yeast Saccharomyces cerevisiae that catalyzes the transfer of phosphorylinositol from phosphatidylinositol to ceramide, producing inositol phosphorylceramide (IPC), a key sphingolipid in fungal cell membranes. This protein, encoded by the YKL004W gene, is essential for fungal viability and contributes to maintaining membrane integrity and signaling pathways in yeast. AUR1 is not a therapeutic target in humans, as it is absent in mammalian cells, making it relevant primarily for antifungal drug discovery rather than human diseases. The protein confers resistance to aureobasidin A, a cyclic lipopeptide antifungal that specifically inhibits its enzymatic activity, highlighting its role in fungal-specific lipid metabolism. Structural predictions from AlphaFold and domain analyses reveal conserved motifs typical of glycosyltransferases involved in lipid modification. Note that AUR1 should not be confused with aurora kinases (e.g., Arabidopsis thaliana AUR1, a serine/threonine-protein kinase), as it is a distinct fungal enzyme. Overall, AUR1 exemplifies a fungal-specific target exploited for selective antifungal agents without human off-target effects.

Other names
Aureobasidin A resistance proteinIPC synthase catalytic subunit AUR1
02

Mechanism of action

Inhibition of inositol phosphorylceramide synthase activity

03

Biological functions

Sphingolipid biosynthesisCeramide phosphorylation
04

Interacting drugs

Aureobasidin A

Beyond the preview

Go deeper on Inositol phosphorylceramide synthase catalytic subunit AUR1 (AUR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol phosphorylceramide synthase catalytic subunit AUR1 (AUR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call